Navigation Links
Vasogen Receives NASDAQ Notification Related to Minimum Bid Price
Date:4/25/2008

any additional compliance period, NASDAQ will provide written notice to the Company that its securities will be delisted from the NASDAQ Capital Market.

About Vasogen

Vasogen is a biotechnology company engaged in the research and development of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders.

Certain statements contained in this press release, or elsewhere in our public documents constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and/or "forward-looking information" under the Securities Act (Ontario). These statements may include, without limitation, plans to advance the development of the Celacade(TM) System or our VP Series of drugs including VP015 and VP025, plans to fund our current activities, statements concerning our partnering activities, health regulatory submissions, strategy, future operations, future financial position, future revenues and projected costs. In some cases, you can identify forward-looking statements by terminology such as "may", "will", "should", "expects", "plans", "anticipates", "believes", "estimated", "predicts", "potential", "continue", "intends", "could", or the negative of such terms or other comparable terminology. We made a number of assumptions in the preparation of these forward-looking statements, including assumptions about the nature, size, and accessibility of the market for Celacade in the treatment of chronic heart failure, particularly in Europe, the regulatory approval process leading to commercialization and the availability of capital on acceptable terms to pursue the development of Celacade, and the feasibility of additional trials. You should not place undue reliance on our forward-looking statements which are subject to a multitude of risks and uncertainties that could cause actual results, future circum
'/>"/>

SOURCE Vasogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
2. Vasogen Announces Third Quarter 2007 Results
3. Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
4. Vasogen Provides an Update on ACCLAIM-II Preparations
5. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
6. Vasogen to Conduct Year-end 2007 Conference Call
7. Vasogen Announces 2007 Year-End Results
8. The Lancet Publishes Vasogens ACCLAIM Results
9. Vasogens Research Published in European Journal of Neuroscience
10. Vasogen to Present at the BIO CEO & Investor Conference and Participate on the Non-Cancer Immunotherapy Panel
11. Vasogen Provides Update on ACCLAIM II Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... August 19, 2014 Sales Horizons, a ... its online sales skills training course to ... , MedTech clinical staff spend the majority of their ... standalone medical center, or physician practice – providing support ... why stop there? Sales Horizons believes clinical staff are ...
(Date:8/18/2014)... Tampa, FL (Aug. 18, 2014) -- A new ... South Florida (USF) Morsani College of Medicine and ... the life-threatening complications of interventional cardiovascular disease treatment. ... model that the novel molecular therapy could selectively ... healing following a medical procedure using a balloon ...
(Date:8/18/2014)... Md. , Aug. 18, 2014 /PRNewswire/ ... maker of advanced consumer medical devices said ... was interviewed by CEOLIVE.TV as part ... The entire interview is available at ... Dr. Kotak explains to investors the unique ...
(Date:8/18/2014)... efficiency and data storage may someday run ... polarizations to read and write digital information, ... technology. But ferroelectrics must first overcome a ... habit of "forgetting" stored data. , ... Energy,s Brookhaven National Laboratory have discovered nanoscale ...
Breaking Biology Technology:Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 2Sales Horizons Launches a New Online Sales Training Course for MedTech Clinical Staff to Develop Their Sales Skills 3Selective therapy may improve artery repair after interventional cardiovascular procedures 2Selective therapy may improve artery repair after interventional cardiovascular procedures 3BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Promising ferroelectric materials suffer from unexpected electric polarizations 2Promising ferroelectric materials suffer from unexpected electric polarizations 3Promising ferroelectric materials suffer from unexpected electric polarizations 4
... Merge eMed updates eFilm Workstation , Milwaukee, Wis. ... Merge Healthcare company and a leading medical imaging software ... Workstation 2.1 and its plug-in Advanced Visualization and Clinical ... widely used desktop diagnostic imaging software includes customer-driven updates ...
... Norlight Telecommunications has adopted an unconventional ... number of technical jobs. The Wisconsin-based provider of customized ... an external referral bonus program to reward anyone who ... vacancies. , ,Norlight's is encouraging others to refer ...
... Wis. A new report suggests Wisconsin is slowly ... as judged by indicators such as producing patents, investing in ... question: Why are we improving? , ,There is no ... provided were not swamped in a sea of global ...
Cached Biology Technology:Heres why Wisconsins tech economy indicators are up 2Heres why Wisconsins tech economy indicators are up 3
(Date:8/19/2014)... from fish purchased at retail seafood counters in ... mislabeling can expose consumers to unexpectedly high levels ... "substitutions"which falsely present a fish of the same ... most dangerous mislabeling offense, according to new research ... "Accurate labeling of seafood is essential to allow ...
(Date:8/19/2014)... Two Northwestern University scientists have identified a biomarker ... aggressive carcinoma that is resistant to many types ... provides a smart target for new therapeutics designed ... breast cancer patient data taken from The Cancer ... Robert W. Tell used powerful computational and bioinformatics ...
(Date:8/19/2014)... -- Scientists at the Houston Methodist Research Institute have ... cells using a pipette -- a common laboratory tool ... and preliminary test results in a recent issue of ... , "Studying single cells and their unique functions has ... department. faculty member Lidong Qin, Ph.D., the project,s principal ...
Breaking Biology News(10 mins):Seafood substitutions can expose consumers to unexpectedly high mercury 2Seafood substitutions can expose consumers to unexpectedly high mercury 3Biomarker in an aggressive breast cancer is identified 2Biomarker in an aggressive breast cancer is identified 3Moving single cells around -- accurately and cheaply 2
... urban areas face more predators than do those in rural ... nest robbers. A six-year study conducted in 19 central ... rural areas that had higher numbers of nest predators such ... of nest survival. But there was no relation between ...
... Across the globe, the diversity of plant and animal species ... Equator but surprisingly that rule isn,t true for soil bacteria, ... Paul Grogan. "It appears that the rules determining the ... rules for bacteria," says Professor Grogan. The finding is ...
... the National Academy of Engineering and National Research Council ... the Deepwater Horizon explosion and oil spill will hold ... head of safety and operations for BP, and other ... Also on the agenda are Thomas Roth, vice ...
Cached Biology News:More predators doesn't equal more danger for urban bird nest 2
sterile filtered, off the clot, all male donors, Total Protein: 4.5 to 8.5 g/dl...
Recombinant Mouse MMP-9, CF...
Human/Mouse/Rat JNK Pan Specific Affinity Purified PAb...
Blue Standard is 3-cyano-7-hydroxycoumarin....
Biology Products: